chr14-65006478-G-A
Variant names: 
Variant summary
Our verdict is Benign. The variant received -14 ACMG points: 0P and 14B. BP4_StrongBP6_ModerateBA1
The NM_002028.4(FNTB):c.209+2165G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.563 in 152,034 control chromosomes in the GnomAD database, including 24,732 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★).
Frequency
 Genomes: 𝑓 0.56   (  24732   hom.,  cov: 32) 
Consequence
 FNTB
NM_002028.4 intron
NM_002028.4 intron
Scores
 2
Clinical Significance
Conservation
 PhyloP100:  -0.561  
Publications
13 publications found 
Genes affected
 FNTB  (HGNC:3785):  (farnesyltransferase, CAAX box, beta) Enables zinc ion binding activity. Contributes to protein farnesyltransferase activity. Involved in protein farnesylation. Part of microtubule associated complex and protein farnesyltransferase complex. [provided by Alliance of Genome Resources, Apr 2022] 
 CHURC1-FNTB  (HGNC:42960):  (CHURC1-FNTB readthrough) This locus represents naturally occurring read-through transcription between the neighboring CHURC1 (churchill domain containing 1) and FNTB (farnesyltransferase, CAAX box, beta) on chromosome 14. The read-through transcript produces a fusion protein that shares sequence identity with each individual gene product. [provided by RefSeq, Feb 2011] 
 MAX  (HGNC:6913):  (MYC associated factor X) The protein encoded by this gene is a member of the basic helix-loop-helix leucine zipper (bHLHZ) family of transcription factors. It is able to form homodimers and heterodimers with other family members, which include Mad, Mxi1 and Myc. Myc is an oncoprotein implicated in cell proliferation, differentiation and apoptosis. The homodimers and heterodimers compete for a common DNA target site (the E box) and rearrangement among these dimer forms provides a complex system of transcriptional regulation. Mutations of this gene have been reported to be associated with hereditary pheochromocytoma. A pseudogene of this gene is located on the long arm of chromosome 7. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2012] 
MAX Gene-Disease associations (from GenCC):
- hereditary pheochromocytoma-paragangliomaInheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen
- pheochromocytomaInheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Labcorp Genetics (formerly Invitae)
- polydactyly-macrocephaly syndromeInheritance: AD Classification: LIMITED Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -14 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95). 
BP6
Variant 14-65006478-G-A is Benign according to our data. Variant chr14-65006478-G-A is described in ClinVar as Benign. ClinVar VariationId is 1233970.Status of the report is criteria_provided_single_submitter, 1 stars. 
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.683  is higher than 0.05. 
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| FNTB | NM_002028.4 | c.209+2165G>A | intron_variant | Intron 2 of 11 | ENST00000246166.3 | NP_002019.1 | 
Ensembl
Frequencies
GnomAD3 genomes  0.563  AC: 85513AN: 151914Hom.:  24685  Cov.: 32 show subpopulations 
GnomAD3 genomes 
 AF: 
AC: 
85513
AN: 
151914
Hom.: 
Cov.: 
32
Gnomad AFR 
 AF: 
Gnomad AMI 
 AF: 
Gnomad AMR 
 AF: 
Gnomad ASJ 
 AF: 
Gnomad EAS 
 AF: 
Gnomad SAS 
 AF: 
Gnomad FIN 
 AF: 
Gnomad MID 
 AF: 
Gnomad NFE 
 AF: 
Gnomad OTH 
 AF: 
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome  0.563  AC: 85636AN: 152034Hom.:  24732  Cov.: 32 AF XY:  0.564  AC XY: 41931AN XY: 74308 show subpopulations 
GnomAD4 genome 
 AF: 
AC: 
85636
AN: 
152034
Hom.: 
Cov.: 
32
 AF XY: 
AC XY: 
41931
AN XY: 
74308
show subpopulations 
African (AFR) 
 AF: 
AC: 
28579
AN: 
41438
American (AMR) 
 AF: 
AC: 
8317
AN: 
15278
Ashkenazi Jewish (ASJ) 
 AF: 
AC: 
1526
AN: 
3470
East Asian (EAS) 
 AF: 
AC: 
3065
AN: 
5170
South Asian (SAS) 
 AF: 
AC: 
2127
AN: 
4822
European-Finnish (FIN) 
 AF: 
AC: 
6161
AN: 
10578
Middle Eastern (MID) 
 AF: 
AC: 
107
AN: 
294
European-Non Finnish (NFE) 
 AF: 
AC: 
34115
AN: 
67966
Other (OTH) 
 AF: 
AC: 
1090
AN: 
2110
 Allele Balance Distribution 
 Red line indicates average allele balance 
 Average allele balance: 0.501 
Heterozygous variant carriers
 0 
 1893 
 3787 
 5680 
 7574 
 9467 
 0.00 
 0.20 
 0.40 
 0.60 
 0.80 
 0.95 
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
 0 
 724 
 1448 
 2172 
 2896 
 3620 
 <30 
 30-35 
 35-40 
 40-45 
 45-50 
 50-55 
 55-60 
 60-65 
 65-70 
 70-75 
 75-80 
 >80 
Age
Alfa 
 AF: 
Hom.: 
Bravo 
 AF: 
Asia WGS 
 AF: 
AC: 
1866
AN: 
3478
ClinVar
Significance: Benign 
Submissions summary: Benign:1 
Revision: criteria provided, single submitter
LINK: link 
Submissions by phenotype
not provided    Benign:1 
Jun 15, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing
- -
Computational scores
Source: 
Name
Calibrated prediction
Score
Prediction
 BayesDel_noAF 
 Benign 
 DANN 
 Benign 
 PhyloP100 
Splicing
Name
Calibrated prediction
Score
Prediction
 SpliceAI score (max) 
Details are displayed if max score is > 0.2
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at 
Publications
 You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.